Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies

References

• Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin. Infect. Dis 43 (1), S3–S14 (2006).
   Web of Science ®Google Scholar
• Pagano L, Caira M, Candoni A et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91(8), 1068–1075 (2006).
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34(7), 909–917 (2002).
   PubMed Web of Science ®Google Scholar
• Pagano L, Caira M, Nosari A et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study–Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin. Infect. Dis. 45(9), 1161–1170 (2007).
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52(3), 197–205 (2009).
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Rosa DD, Medeiros LR, Severo LC. Candidaemia and cancer: patients are not all the same. BMC Infect. Dis. 6, 50 (2006).
   PubMedGoogle Scholar
• Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325(18), 1274–1277 (1991).
   PubMed Web of Science ®Google Scholar
• Lionakis MS, Lewis RE, Torres HA, Albert ND, Raad II, Kontoyiannis DP. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagn. Microbiol. Infect. Dis. 52(1), 15–20 (2005).
   PubMed Web of Science ®Google Scholar
• Richardson M, Lass-Flörl C. Changing epidemiology of systemic fungal infections. Clin. Microbiol. Infect. 14(Suppl. 4), 5–24 (2008).
   PubMed Web of Science ®Google Scholar
• Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49(9), 3640–3645 (2005).
   PubMed Web of Science ®Google Scholar
• Heussel CP, Kauczor HU, Heussel GE et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J. Clin. Oncol. 17(3), 796–805 (1999).
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP et al.; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46(12), 1813–1821 (2008).
   PubMed Web of Science ®Google Scholar
• Preuner S, Lion T. Towards molecular diagnostics of invasive fungal infections. Expert Rev. Mol. Diagn. 9(5), 397–401 (2009).
   PubMed Web of Science ®Google Scholar
• Lease ED, Alexander BD. Fungal diagnostics in pneumonia. Semin. Respir. Crit. Care Med. 32(6), 663–672 (2011).
   PubMed Web of Science ®Google Scholar
• Wirk B, Wingard JR. Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients. Mycopathologia 168(6), 299–311 (2009).
   PubMed Web of Science ®Google Scholar
• Reimer LG, Wilson ML, Weinstein MP. Update on detection of bacteremia and fungemia. Clin. Microbiol. Rev. 10(3), 444–465 (1997).
   PubMed Web of Science ®Google Scholar
• Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 5(10), 609–622 (2005).
   PubMed Web of Science ®Google Scholar
• Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J. Microbiol. 43, 65–84 (2005).
   PubMed Web of Science ®Google Scholar
• Simoneau E, Kelly M, Labbe AC, Roy J, Laverdière M. What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant. 35(3), 303–306 (2005).
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Bassetti M, Lass-Flörl C, Rácil Z, Richardson M, Rogers TR. Detection and investigation of invasive mould disease. J. Antimicrob. Chemother. 66(Suppl. 1), i15–i24 (2011).
   Google Scholar
• Caillot D, Couaillier JF, Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J. Clin. Oncol. 19(1), 253–259 (2001).
   PubMed Web of Science ®Google Scholar
• Barnes RA. Early diagnosis of fungal infection in immunocompromised patients. J. Antimicrob. Chemother. 61(Suppl. 1), i3–i6 (2008).
   PubMed Web of Science ®Google Scholar
• Greene RE, Schlamm HT, Oestmann JW et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin. Infect. Dis. 44(3), 373–379 (2007).
   PubMed Web of Science ®Google Scholar
• Maertens JA, Klont R, Masson C et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin. Infect. Dis. 44(10), 1329–1336 (2007).
   PubMed Web of Science ®Google Scholar
• Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42(10), 1417–1427 (2006).
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Letscher-Bru V, Oprea C et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J. Clin. Oncol. 20(7), 1898–1906 (2002).
   PubMed Web of Science ®Google Scholar
• Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J. Infect. Dis. 190(3), 641–649 (2004).
   PubMed Web of Science ®Google Scholar
• Koo S, Bryar JM, Baden LR, Marty FM. Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J. Clin. Microbiol. 48(4), 1255–1260 (2010).
   PubMed Web of Science ®Google Scholar
• Maertens J, Buvé K, Theunissen K et al. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 115(2), 355–362 (2009).
   PubMed Web of Science ®Google Scholar
• Miceli MH, Grazziutti ML, Woods G et al. Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin. Infect. Dis. 46(9), 1412–1422 (2008).
   PubMed Web of Science ®Google Scholar
• Bergeron A, Belle A, Sulahian A et al. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 137(2), 410–415 (2010).
   PubMed Web of Science ®Google Scholar
• Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 42(12), 5517–5522 (2004).
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Leather H, Clancy CJ et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol. Blood Marrow Transplant. 17(7), 1043–1050 (2011).
   PubMed Web of Science ®Google Scholar
• Maertens J, Maertens V, Theunissen K et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 49(11), 1688–1693 (2009).
   PubMed Web of Science ®Google Scholar
• Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br. J. Haematol. 121(3), 448–457 (2003).
   PubMed Web of Science ®Google Scholar
• Mikulska M, Furfaro E, Del Bono V et al. Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assay. J. Antimicrob. Chemother. 67(7), 1746–1748 (2012).
   PubMed Web of Science ®Google Scholar
• Viscoli C, Machetti M, Gazzola P et al. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J. Clin. Microbiol. 40(4), 1496–1499 (2002).
   PubMed Web of Science ®Google Scholar
• Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 40(12), 1762–1769 (2005).
   PubMed Web of Science ®Google Scholar
• Viscoli C, Machetti M, Cappellano P et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin–tazobactam. Clin. Infect. Dis. 38(6), 913–916 (2004).
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect. Dis. 4(6), 349–357 (2004).
   PubMed Web of Science ®Google Scholar
• Boonsarngsuk V, Niyompattama A, Teosirimongkol C, Sriwanichrak K. False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics. Scand. J. Infect. Dis. 42(6–7), 461–468 (2010).
   PubMed Web of Science ®Google Scholar
• Zandijk E, Mewis A, Magerman K, Cartuyvels R. False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin–clavulanate. Clin. Vaccine Immunol. 15(7), 1132–1133 (2008).
   PubMedGoogle Scholar
• Mori Y, Nagasaki Y, Kamezaki K et al. High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. Am. J. Hematol. 85(6), 449–451 (2010).
   PubMed Web of Science ®Google Scholar
• Hage CA, Reynolds JM, Durkin M, Wheat LJ, Knox KS. Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. J. Clin. Microbiol. 45(2), 676–677 (2007).
   PubMed Web of Science ®Google Scholar
• Chen SC, Kontoyiannis DP. New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr. Opin. Infect. Dis. 23(6), 567–577 (2010).
   PubMed Web of Science ®Google Scholar
• Mulanovich VE, Kontoyiannis DP. Fungal pneumonia in patients with hematologic malignancies: current approach and management. Curr. Opin. Infect. Dis. 24, 323–332 (2011).
   PubMed Web of Science ®Google Scholar
• Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1–>3)-β-d-glucan assay for invasive fungal disease. Clin. Infect. Dis. 49(11), 1650–1659 (2009).
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E et al. β-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39(2), 199–205 (2004).
   PubMed Web of Science ®Google Scholar
• Lamoth F, Cruciani M, Mengoli C et al.; Third European Conference on Infections in Leukemia (ECIL-3). b-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin. Infect. Dis. 54(5), 633–643 (2012).
   PubMed Web of Science ®Google Scholar
• Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1->3)-β-d-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43(12), 5957–5962 (2005).
   PubMed Web of Science ®Google Scholar
• Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. Reactivity of (1–>3)-β-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob. Agents Chemother. 50(10), 3450–3453 (2006).
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Ruegebrink D, Verweij PE. Pseudomonas aeruginosa as a cause of 1,3-β-d-glucan assay reactivity. Clin. Infect. Dis. 46(12), 1930–1931 (2008).
   PubMed Web of Science ®Google Scholar
• Pazos C, Pontón J, Del Palacio A. Contribution of (1->3)-β-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microbiol. 43(1), 299–305 (2005).
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Meije Y, Diaz-Pedroche C et al. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive Aspergillosis in patients with febrile neutropenia. J. Clin. Microbiol. 47(2), 379–384 (2009).
   PubMed Web of Science ®Google Scholar
• Florent M, Katsahian S, Vekhoff A et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J. Infect. Dis. 193(5), 741–747 (2006).
   PubMed Web of Science ®Google Scholar
• Kami M, Fukui T, Ogawa S et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin. Infect. Dis. 33(9), 1504–1512 (2001).
   PubMed Web of Science ®Google Scholar
• Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect. Dis. 9(2), 89–96 (2009).
   PubMed Web of Science ®Google Scholar
• Lau A, Chen S, Sorrell T et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J. Clin. Microbiol. 45(2), 380–385 (2007).
   PubMed Web of Science ®Google Scholar
• Spiess B, Seifarth W, Hummel M et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J. Clin. Microbiol. 45(11), 3743–3753 (2007).
   PubMed Web of Science ®Google Scholar
• Harrison E, Stalhberger T, Whelan R et al. Aspergillus Technology Consortium (AsTeC). Aspergillus DNA contamination in blood collection tubes. Diagn. Microbiol. Infect. Dis. 67(4), 392–394 (2010).
   PubMed Web of Science ®Google Scholar
• White PL, Bretagne S, Klingspor L et al. European Aspergillus PCR Initiative. Aspergillus PCR: one step closer to standardization. J. Clin. Microbiol. 48(4), 1231–1240 (2010).
   PubMed Web of Science ®Google Scholar
• Wingard JR. New approaches to invasive fungal infections in acute leukemia and hematopoietic stem cell transplant patients. Best Pract. Res. Clin. Haematol. 20(1), 99–107 (2007).
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34(6), 730–751 (2002).
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 52(4), 427–431 (2011).
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Teppler H, Donowitz GR et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N. Engl. J. Med. 351(14), 1391–1402 (2004).
   PubMed Web of Science ®Google Scholar
• de Pauw BE. Between over- and undertreatment of invasive fungal disease. Clin. Infect. Dis. 41(9), 1251–1253 (2005).
   PubMed Web of Science ®Google Scholar
• Bennett JE, Powers J, Walsh T et al. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. Clin. Infect. Dis. 36(Suppl. 3), 117–122 (2003).
   PubMed Web of Science ®Google Scholar
• Mikolajewska A, Schwartz S, Ruhnke M. Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy. Mycoses 55(1), 2–16 (2012).
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Pautas C, Maury S et al. Empirical versus pre-emptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin. Infect. Dis. 48(8), 1042–1051 (2009).
   PubMed Web of Science ®Google Scholar
• Hebart H, Klingspor L, Klingebiel T et al. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant. 43(7), 553–561 (2009).
   PubMed Web of Science ®Google Scholar
• Maertens J, Theunissen K, Verhoef G et al. Galactomannan and computed tomography-based pre-emptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin. Infect. Dis. 41(9), 1242–1250 (2005).
   PubMed Web of Science ®Google Scholar
• Maertens J, Marchetti O, Herbrecht R et al.; Third European Conference on Infections in Leukemia. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3–2009 update. Bone Marrow Transplant. 46(5), 709–718 (2011).
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 52(4), e56–e93 (2011).
   PubMed Web of Science ®Google Scholar